Related Experiment Video
Updated: Jun 3, 2026
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Coagulopathy in Beta-thalassemia: current understanding and future perspectives
M Domenica Cappellini1, Khaled M Musallam, Alessia Marcon
1Universitá di Milano, Policlinico Foundation IRCCS, Milan, Italy.
Mediterranean Journal of Hematology and Infectious Diseases
|March 19, 2011
Summary
Beta-thalassemia patients face increased clotting risk due to a hypercoagulable state. This review explores the mechanisms behind this condition and discusses thrombosis prophylaxis strategies for improved patient care.
Area of Science:
- Hematology
- Vascular Biology
- Thrombosis Research
Background:
- Improved life expectancy in beta-thalassemia patients reveals new complications.
- Thalassemia intermedia patients exhibit a high incidence of thromboembolic events.
Purpose of the Study:
- To review the molecular and cellular mechanisms of hypercoagulability in thalassemia.
- To summarize current clinical experiences with thrombosis in thalassemia.
- To discuss recommendations for thrombosis prophylaxis.
Main Methods:
- Literature review of molecular and cellular mechanisms.
- Synthesis of current clinical data on thromboembolic events.
- Analysis of existing thrombosis prophylaxis guidelines.
Main Results:
- Identification of a hypercoagulable state in thalassemia.
- Specific molecular and cellular pathways contributing to increased clotting risk are highlighted.
- Clinical evidence points to a significant burden of thromboembolic events.
Conclusions:
- Thrombosis is a major concern in beta-thalassemia, particularly thalassemia intermedia.
- Understanding the mechanisms of hypercoagulability is crucial for management.
- Prophylaxis strategies are essential to mitigate thromboembolic risks.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:20Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...